Sign in

CIK 0002042347 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Seaport Therapeutics, Inc.

Sign in to watch
Ticker
SPTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
992235719
Phone
617-807-4062
Business address
6 TIDE STREET, SUITE 400, BOSTON, MA, 02110
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Conversion General Counsel acquired 33,515 shares (conversion)
  4. 4 Conversion Chief Scientific Officer acquired 3,351 shares (conversion)
  5. 4 Conversion Director acquired 13,406 shares (conversion)
  6. 4 Conversion Director acquired 67,031 shares (conversion)
  7. 4 Open-market buy 10% owner bought 1,100,000 shares at $18.00 ($19,800,000)
  8. 4 Derivatives Options or other derivatives
  9. 4 Conversion Chief Medical Officer acquired 20,109 shares (conversion)
  10. 4 Derivatives Options or other derivatives
  11. 8-K Event Bylaws or fiscal year change
  12. S-8 Other Securities Offered to Employees in Benefit Plans
  13. 424B4 Offering Prospectus
  14. EFFECT Other Notice of Effectiveness
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 2 of 3 · 58 filings